
|Articles|November 26, 2012
Ranbaxy recalls atorvastatin calcium tablets in 10-, 20-, 40-mg dosages
More than 40 lots of atorvastatin calcium tablets, the generic version of Pfizer?s Lipitor, are being recalled by Ranbaxy Pharmaceuticals Inc. (RPI) because they may contain glass particles that are estimated to be less than 1 mm in size, according to Ranbaxy's website.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: Community Pharmacists Educate Patients on Safe Insulin Use
2
Targeted Coordination Is Crucial in Boosting Pneumococcal Vaccine Coverage
3
Scripted for Her: HRT Black Box Removal
4
Trump Executive Order Set to Reclassify Marijuana, Improve CBD Access
5
















































































































